Cargando…
Mycobacterium tuberculosis Drug Resistance, Abkhazia
Autores principales: | Pardini, Manuela, Iona, Elisabetta, Varaine, Francis, Karakozian, Hayk, Arzumanian, Herchanik, Brunori, Lara, Orefici, Graziella, Fattorini, Lanfranco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298253/ https://www.ncbi.nlm.nih.gov/pubmed/15789491 http://dx.doi.org/10.3201/eid1103.040903 |
Ejemplares similares
-
Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection
por: Bonnet, Maryline, et al.
Publicado: (2011) -
The genomic origin of Zana of Abkhazia
por: Margaryan, Ashot, et al.
Publicado: (2021) -
Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner
por: Iacobino, Angelo, et al.
Publicado: (2021) -
Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004) -
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
por: Lanni, Alessio, et al.
Publicado: (2023)